- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-hexamer
- Ligands
- 3 x MK1: N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE(Non-covalent)
- 39 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: P.4, R.9, R.10, P.11
Ligand excluded by PLIPSO4.3: 4 residues within 4Å:- Chain A: P.7, A.8, R.10
- Chain B: D.36
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: R.9
- Chain E: R.9
Ligand excluded by PLIPSO4.5: 8 residues within 4Å:- Chain A: Q.16, P.24, K.25, T.26
- Chain F: D.18, Q.20, L.75
- Ligands: SO4.6
Ligand excluded by PLIPSO4.6: 6 residues within 4Å:- Chain A: Q.16, T.26
- Chain F: L.75, R.77
- Ligands: SO4.5, PG4.12
Ligand excluded by PLIPSO4.7: 1 residues within 4Å:- Chain A: Q.20
Ligand excluded by PLIPSO4.8: 5 residues within 4Å:- Chain A: L.78, T.83, I.85, Q.108, C.109
Ligand excluded by PLIPSO4.9: 2 residues within 4Å:- Chain A: V.86, Q.108
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain A: F.80, R.81, T.82, T.83
Ligand excluded by PLIPSO4.11: 5 residues within 4Å:- Chain A: I.27, E.28, A.99
- Chain F: S.71, P.73
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain B: K.14, A.15, T.26, P.79
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain B: R.81, T.83, I.85, Q.108, C.109
Ligand excluded by PLIPSO4.15: 5 residues within 4Å:- Chain B: I.27, E.28, P.41, N.97, A.99
Ligand excluded by PLIPSO4.17: 4 residues within 4Å:- Chain C: P.4, R.9, R.10, P.11
Ligand excluded by PLIPSO4.18: 4 residues within 4Å:- Chain C: P.7, A.8, R.10
- Chain D: D.36
Ligand excluded by PLIPSO4.19: 2 residues within 4Å:- Chain A: R.9
- Chain C: R.9
Ligand excluded by PLIPSO4.20: 8 residues within 4Å:- Chain B: D.18, Q.20, L.75
- Chain C: Q.16, P.24, K.25, T.26
- Ligands: SO4.21
Ligand excluded by PLIPSO4.21: 6 residues within 4Å:- Chain B: L.75, R.77
- Chain C: Q.16, T.26
- Ligands: SO4.20, PG4.27
Ligand excluded by PLIPSO4.22: 1 residues within 4Å:- Chain C: Q.20
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain C: L.78, T.83, I.85, Q.108, C.109
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain C: V.86, Q.108
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain C: F.80, R.81, T.82, T.83
Ligand excluded by PLIPSO4.26: 5 residues within 4Å:- Chain B: S.71, P.73
- Chain C: I.27, E.28, A.99
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain D: K.14, A.15, T.26, P.79
Ligand excluded by PLIPSO4.29: 5 residues within 4Å:- Chain D: R.81, T.83, I.85, Q.108, C.109
Ligand excluded by PLIPSO4.30: 5 residues within 4Å:- Chain D: I.27, E.28, P.41, N.97, A.99
Ligand excluded by PLIPSO4.32: 4 residues within 4Å:- Chain E: P.4, R.9, R.10, P.11
Ligand excluded by PLIPSO4.33: 4 residues within 4Å:- Chain E: P.7, A.8, R.10
- Chain F: D.36
Ligand excluded by PLIPSO4.34: 2 residues within 4Å:- Chain C: R.9
- Chain E: R.9
Ligand excluded by PLIPSO4.35: 8 residues within 4Å:- Chain D: D.18, Q.20, L.75
- Chain E: Q.16, P.24, K.25, T.26
- Ligands: SO4.36
Ligand excluded by PLIPSO4.36: 6 residues within 4Å:- Chain D: L.75, R.77
- Chain E: Q.16, T.26
- Ligands: SO4.35, PG4.42
Ligand excluded by PLIPSO4.37: 1 residues within 4Å:- Chain E: Q.20
Ligand excluded by PLIPSO4.38: 5 residues within 4Å:- Chain E: L.78, T.83, I.85, Q.108, C.109
Ligand excluded by PLIPSO4.39: 2 residues within 4Å:- Chain E: V.86, Q.108
Ligand excluded by PLIPSO4.40: 4 residues within 4Å:- Chain E: F.80, R.81, T.82, T.83
Ligand excluded by PLIPSO4.41: 5 residues within 4Å:- Chain D: S.71, P.73
- Chain E: I.27, E.28, A.99
Ligand excluded by PLIPSO4.43: 4 residues within 4Å:- Chain F: K.14, A.15, T.26, P.79
Ligand excluded by PLIPSO4.44: 5 residues within 4Å:- Chain F: R.81, T.83, I.85, Q.108, C.109
Ligand excluded by PLIPSO4.45: 5 residues within 4Å:- Chain F: I.27, E.28, P.41, N.97, A.99
Ligand excluded by PLIP- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
PG4.12: 10 residues within 4Å:- Chain A: K.14, Q.16, T.26, R.77, L.78, P.79, R.81
- Chain F: P.84, V.86
- Ligands: SO4.6
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:F.80
PG4.27: 10 residues within 4Å:- Chain B: P.84, V.86
- Chain C: K.14, Q.16, T.26, R.77, L.78, P.79, R.81
- Ligands: SO4.21
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:F.80
PG4.42: 10 residues within 4Å:- Chain D: P.84, V.86
- Chain E: K.14, Q.16, T.26, R.77, L.78, P.79, R.81
- Ligands: SO4.36
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:F.80
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kuhnert, M. et al., Structural basis for HTLV-1 protease inhibition by the HIV-1 protease inhibitor indinavir. J.Med.Chem. (2014)
- Release Date
- 2014-10-22
- Peptides
- Protease: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-hexamer
- Ligands
- 3 x MK1: N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE(Non-covalent)
- 39 x SO4: SULFATE ION(Non-functional Binders)
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kuhnert, M. et al., Structural basis for HTLV-1 protease inhibition by the HIV-1 protease inhibitor indinavir. J.Med.Chem. (2014)
- Release Date
- 2014-10-22
- Peptides
- Protease: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B